Stock Price & Analysis

Based on the provided data and recent market events, here's a concise analysis of UNH stock:

Recent Price Movement

Technical Analysis

• Stock has experienced significant downward pressure, falling sharply by -7.17% on February 21, 2025
• Currently trading at $465.87, well below its 200-day moving average of $544.59
• RSI reading of 27.74 indicates oversold conditions
• MACD shows bearish momentum with negative divergence

Fundamental Catalysts

• Department of Justice has launched an investigation into UnitedHealth's Medicare billing practices, triggering the recent sharp decline
• The investigation news has created significant uncertainty around the company's future regulatory risks
• Prior to this news, analysts maintained largely bullish ratings with a consensus price target of $663

Market Position

• UnitedHealth remains one of the largest private health insurers with approximately 51 million members globally
• Strong market leadership in employer-sponsored, self-directed, and government-backed insurance plans
• Continued investments in Optum franchises provide diversification

Recommendation Given the significant regulatory uncertainty and technical weakness, investors should avoid initiating new positions at current levels. The DOJ investigation could create continued pressure on the stock price in the near term, despite the company's strong fundamental business position.

Based on the available data and market analysis, here's the price prediction for UNH stock in 2025:

UnitedHealth Group (UNH) is projected to reach $609-650 by end of 2025, driven by expected EPS growth acceleration to 13-16% range and potential multiple expansion to 19x earnings from current 17x. The company's strong Medicare Advantage member retention rates and favorable rate environment under anticipated Trump administration support this bullish outlook. However, elevated medical costs reported in recent quarters could pose some headwinds to this target.

The S1 support level for UNH Stock is $452.55 ,The R1 resistant level for UNH Stock is $531.89.

As of the end of day on 2025-02-27, the price of UNH Stock was $470.96.

The target price for UNH Stock according to analyst rating is 642.18, with the highest price target at 700.00 and the lowest at 595.00. Analysts have a Strong Buy rating on UNH Stock overall.

The market cap of UNH is $426.6B.

Based on the provided data and recent market activity, here is a concise analysis of UNH's valuation:

Technical Analysis

The stock shows significant bearish momentum with RSI at 27.74 indicating oversold conditions. The stock is trading below all major moving averages (5,10,20,60,200-day), suggesting strong downward pressure.

Recent Price Movement

• Current price: $466.42 (-7.17% today)
• Major decline triggered by DOJ investigation news into Medicare billing practices
• Trading volume spiked to 19.8M shares, significantly above average

Valuation Metrics

• P/E (2023): 22.06x
• EV/EBITDA (2023): 14.84x
• P/S (2023): 1.33x
• P/B (2023): 5.48x

Fundamental Analysis

• Revenue growth: +14.6% YoY ($371.3B in 2023)
• Net income growth: +11.2% YoY ($22.4B in 2023)
• ROE remains strong at 26.88%
• Net margin slightly decreased to 6.23% in 2023

Key Concerns

• DOJ investigation into Medicare billing practices
• Rising medical costs impacting profitability
• Public scrutiny over claim denials and healthcare access

Conclusion: Based on the analysis, UNH appears overvalued at current levels due to:

1. Trading at premium multiples despite regulatory headwinds
2. Significant technical weakness
3. Margin pressure from rising medical costs
4. Regulatory risks from DOJ investigation

UnitedHealth Group Incorporated is a healthcare company. The Company has two businesses, Optum and UnitedHealthcare. Optum serves the health care marketplace, including patients and consumers, payers, care providers, employers, governments and life sciences companies. UnitedHealthcare offers a full range of health benefits designed to simplify the health care experience and make it more affordable for consumers to access care. UnitedHealthcare Employer & Individual serves consumers and employers, ranging from sole proprietorships to large, multi-site and national employers and public sector employers. UnitedHealthcare Medicare & Retirement delivers health and well-being benefits to seniors and other Medicare eligible consumers. The Company’s segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. UnitedHealthcare segment includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State.

Based on the provided data and recent market analysis, here is a projection for UnitedHealth (UNH) stock price in 2030:

UNH stock is projected to reach $650-700 by 2030, driven by strong Medicare Advantage member retention rates and potential margin expansion under anticipated policy changes. KeyBanc analysts forecast EPS growth returning to 13-16% range by 2026, supporting higher valuation multiples of around 19x earnings versus current 17x.

The company's strategic positioning in healthcare technology and analytics capabilities, combined with its diversified portfolio across UnitedHealth and Optum segments, provides a sustainable competitive advantage for long-term growth.

UNH has a total of 440000 employees.